Anti‐TNF therapy in rheumatoid arthritis: the role of primary care

With increasingly complex drug combinations and new biological drugs being used, there is a need for good communication between primary and secondary care for optimal RA management. This article addresses the issues that may arise in the shared management of patients on anti‐TNF therapies. Copyright © 2010 Wiley Interface Ltd